Patent Yard Sign in
Canadian application, no grantCanada

Macrophage scavenger receptor antagonists

CA 2377288 A1 · Owner: Franz, Robert G. · Inventors: Franz, Robert G.; Gaitanopoulos, Dimitri E.; Weinstock, Joseph

CIPO record

Overview

Drawings and full text

Its claims, description and drawings are in the Canadian Patents Database.

Open the CIPO record

Abstract From the Canadian patent

Macrophage scavenger receptor antagonists are provided. Methods of treating cardiovascular disease comprising administration of the present compounds are also provided. The present compounds inhibit lipid accumulation within macrophage-derived foam cells.

Read the whole patent

Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.

Why it's free to use

  • Filed June 21, 2000. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended June 21, 2020.
  • A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by June 21, 2022.
  • We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
FiledJune 21, 2000
GrantedNo grant recorded
Term endedJune 21, 2020
Patent numberCA 2377288 A1
Classification (IPC)A01N41/06 +2 more

Timeline

Timeline From CIPO dates

2001200320052007200920112013201520172019Application filedJune 21, 2000Term endedJune 21, 2020

Sources & verification

Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.